Craig A. Mullen, M.D., Ph.D.

Craig A. Mullen, M.D., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 777
Rochester, NY 14642

Office: (585) 275-2981
Fax: (585) 273-1039
Lab: (585) 275-1571

Journal Articles

Showing all 80 journal articles available.

Pahl, K.; Mullen, C.A. "Acute chest syndrome in sickle cell disease: Effect of genotype and asthma". Experimental Biology and Medicine. 2016; 241(7): 745-748. Link
Chen, J.; Mullen, C.A. "Patterns of diagnosis and misdiagnosis in pediatric cancer and relationship to survival". Journal of Pediatric Hematology and Oncology. 2016; .
Tapparello, C; Heinzelman, W; Conn, K; Mullen, CA. "ManageMyCondition: A Standard Framework for the Development of Cloud-based Medical Condition Management Applications". IEEE Xplore: IEEE International Workshop on Cloud Connected Health. 2016; . Link
Tapparello, C; Heinzelman, W; Conn, K; Mullen, CA. "Developing Medical Condition Management Applications Using Manage My Condition". IEEE Xplore: IEEE International Conference on Connected Health: Applications, Systems and Engineering Technologies. 2016; . Link
Hsu YC, Mildenstein K, Hunter K, Tkachenko O, Mullen CA. "Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo." PloS one. 2014 9(2):e88966. Epub 2014 Feb 20.
2013 Apr
Oyeku SO, Driscoll MC, Cohen HW, Trachtman R, Pashankar F, Mullen C, Giardina PJ, Velazco N, Racine AD, Green NS. "Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease." Pediatric blood & cancer. 2013 Apr; 60(4):653-8. Epub 2012 Nov 05.
Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S. "Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea." PloS one. 2013 8(2):e55709. Epub 2013 Feb 07.
Mullen, C.A. "''Good Enough'' Medicine: Noninferiority clinical trials and the management of fever and neutropenia". Pediatric Blood and Cancer. 2012; 59(3): 415-416.
2011 Aug
Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL. "Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease." American journal of hematology. 2011 Aug; 86(8):712-4. Epub 2011 May 31.
2011 Jun
Jansson J, Hsu YC, Kuzin II, Campbell A, Mullen CA. "Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects." Leukemia research. 2011 Jun; 35(6):800-7. Epub 2010 Nov 12.
2011 Feb 15
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America . "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Feb 15; 52(4):e56-93.
2011 Feb
Mullen CA, Campbell A, Tkachenko O, Jansson J, Hsu YC. "Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Feb; 17(2):226-38. Epub 2010 Sep 08.
2010 Nov
Shand JC, Jansson J, Hsu YC, Campbell A, Mullen CA. "Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant." Cancer immunology, immunotherapy : CII. 2010 Nov; 59(11):1633-44. Epub 2010 Jul 03.
2009 Jan
Narang S, Roy J, Stevens TP, Butler-O'Hara M, Mullen CA, D'Angio CT. "Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants." Pediatric blood & cancer. 2009 Jan; 52(1):75-9.
2008 Jun
Young FM, Campbell A, Emo KL, Jansson J, Wang PY, Jordan CT, Mullen CA. "High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Jun; 14(6):622-30. Epub 2008 Apr 14.
2007 Mar
Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA. "Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer." Pediatric blood & cancer. 2007 Mar; 48(3):273-7.
2007 Jan
Natzke AM, Shaw JL, McKeller MR, Emo KL, Mullen CA. "Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Jan; 13(1):34-45.
2006 Sep
Petropoulos D, Worth LL, Mullen CA, Lockhart S, Choroszy M, Chan KW. "Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma." Bone marrow transplantation. 2006 Sep; 38(5):345-9.
2006 Mar
Petropoulos D, Worth LL, Mullen CA, Madden R, Mahajan A, Choroszy M, Ha CS, Champlin RC, Chan KW. "Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies." Bone marrow transplantation. 2006 Mar; 37(5):463-7.
2005 Jul 15
Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV. "Bacterial infections in low-risk, febrile neutropenic patients." Cancer. 2005 Jul 15; 104(2):422-6.
2005 Apr
Mori S, Kocak U, Shaw JL, Mullen CA. "Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire." Bone marrow transplantation. 2005 Apr; 35(8):793-801.
2005 Apr
Mundhada S, Shaw J, Mori S, Savary CA, Mullen CA. "Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses." Leukemia & lymphoma. 2005 Apr; 46(4):571-80.
2004 Nov
Tran H, Petropoulos D, Worth L, Mullen CA, Madden T, Andersson B, Choroszy M, Nguyen J, Webb SK, Chan KW. "Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2004 Nov; 10(11):805-12.
2003 Dec
Mullen CA. "Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients." The Pediatric infectious disease journal. 2003 Dec; 22(12):1138-42.
2003 Oct
Gordon N, Mullen CA, Tran H, Worth L, Gomez Almaguer D, Chan KW. "Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome." Journal of pediatric hematology/oncology. 2003 Oct; 25(10):824-6.
2003 May
Mullen CA, Abd El-Baki H, Samir H, Tarrand JJ, Rolston KV. "Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2003 May; 11(5):321-5. Epub 2003 Mar 11.
2003 May
Mori S, El-Baki H, Mullen CA. "Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation." Bone marrow transplantation. 2003 May; 31(10):865-75.
2002 Oct
Worth LL, Mullen CA, Choroszy M, Koontz S, Chan K. "Treatment of leukemia relapse with recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) following unrelated umbilical cord blood transplant: Induction of graft-vs.-leukemia." Pediatric transplantation. 2002 Oct; 6(5):439-42.
2002 Jul
Farquhar D, Pan BF, Sakurai M, Ghosh A, Mullen CA, Nelson JA. "Suicide gene therapy using E. coli beta-galactosidase." Cancer chemotherapy and pharmacology. 2002 Jul; 50(1):65-70. Epub 2002 Jun 08.
2002 Jun
Chan KW, Mullen CA, Worth LL, Choroszy M, Koontz S, Tran H, Slopis J. "Lorazepam for seizure prophylaxis during high-dose busulfan administration." Bone marrow transplantation. 2002 Jun; 29(12):963-5.
2002 Mar
Mullen CA. "Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation." Leukemia & lymphoma. 2002 Mar; 43(3):503-10.
2002 Jan 1
Wang J, Shaw JL, Mullen CA. "Down-regulation of antihost alloreactivity after bone marrow transplant permits relapse of hematological malignancy." Cancer research. 2002 Jan 1; 62(1):208-12.
2002 Jan
Ko├žak U, Rolston KV, Mullen CA. "Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2002 Jan; 10(1):58-64.
2001 Aug 15
Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. "Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia." Cancer. 2001 Aug 15; 92(4):909-13.
2001 Mar 15
Everse LA, Anderson LD, van Rooijen N, Mullen CA. "Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality." Transplantation. 2001 Mar 15; 71(5):611-8.
2001 Mar
Mullen CA. "Which children with fever and neutropenia can be safely treated as outpatients?" British journal of haematology. 2001 Mar; 112(4):832-7.
2000 Nov
Mullen CA, Chan KW. "Ethical considerations in allogeneic hematopoietic cell transplantation for children with slowly fatal conditions." Bone marrow transplantation. 2000 Nov; 26(9):1030-1.
2000 Oct 15
Anderson LD, Mori S, Mann S, Savary CA, Mullen CA. "Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease." Cancer research. 2000 Oct 15; 60(20):5797-802.
2000 May
Mullen CA, Thompson JN, Richard LA, Chan KW. "Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia." Bone marrow transplantation. 2000 May; 25(10):1093-7.
2000 Apr 1
Anderson LD, Savary CA, Mullen CA. "Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease." Blood. 2000 Apr 1; 95(7):2426-33.
2000 Apr
Candotti F, Agbaria R, Mullen CA, Touraine R, Balzarini J, Johns DG, Blaese RM. "Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer." Cancer gene therapy. 2000 Apr; 7(4):574-80.
2000 Jan
Mullen CA, Nair J, Sandesh S, Chan KW. "Fever and neutropenia in pediatric hematopoietic stem cell transplant patients." Bone marrow transplantation. 2000 Jan; 25(1):59-65.
1999 Nov
Worth L, Tran H, Petropoulos D, Culbert S, Mullen C, Roberts W, Przepiorka D, Chan K. "Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide." Bone marrow transplantation. 1999 Nov; 24(9):947-52.
1999 Jul 1
Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV. "Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients." Cancer. 1999 Jul 1; 86(1):126-34.
1999 Jun
Przepiorka D, Petropoulos D, Mullen CA, Danielson M, Mattewada V, Chan KW. "Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation." Bone marrow transplantation. 1999 Jun; 23(12):1291-5.
1999 May 17
Kuriyama S, Kikukawa M, Masui K, Okuda H, Nakatani T, Sakamoto T, Yoshiji H, Fukui H, Ikenaka K, Mullen CA, Tsujii T. "Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice." International journal of cancer. 1999 May 17; 81(4):592-7.
1999 Apr 1
Anderson LD, Petropoulos D, Everse LA, Mullen CA. "Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine." Cancer research. 1999 Apr 1; 59(7):1525-30.
1999 Jan 1
Ragheb JA, Couture L, Mullen C, Ridgway A, Morgan RA. "Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev." Human gene therapy. 1999 Jan 1; 10(1):103-12.
Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV. "Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer." Journal of pediatric hematology/oncology. 1999 21(3):212-8.
1998 Sep 20
Mullen CA, Anderson L, Woods K, Nishino M, Petropoulos D. "Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses." Human gene therapy. 1998 Sep 20; 9(14):2019-30.
1998 Aug
Chan KW, Mullen CA, Korbling M. "Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosis." Bone marrow transplantation. 1998 Aug; 22(3):301-2.
1998 Jul
Walker RE, Carter CS, Muul L, Natarajan V, Herpin BR, Leitman SF, Klein HG, Mullen CA, Metcalf JA, Baseler M, Falloon J, Davey RT, Kovacs JA, Polis MA, Masur H, Blaese RM, Lane HC. "Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults." Nature medicine. 1998 Jul; 4(7):852-6.
Mullen CA, Petropoulos D, Rytting M, Jeha S, Zipf T, Roberts WM, Rolston KV. "Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia." Journal of pediatric hematology/oncology. 1998 20(5):516-7.
Kuriyama S, Masui K, Sakamoto T, Nakatani T, Kikukawa M, Tsujinoue H, Mitoro A, Yamazaki M, Yoshiji H, Fukui H, Ikenaka K, Mullen CA, Tsujii T. "Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil." Anticancer research. 1998 18(5A):3399-406.
1997 Mar
Ishii-Morita H, Agbaria R, Mullen CA, Hirano H, Koeplin DA, Ram Z, Oldfield EH, Johns DG, Blaese RM. "Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment." Gene therapy. 1997 Mar; 4(3):244-51.
1997 Mar
Kumar A, Kang YH, Gowda K, Mullen CA, Gordon DM, Kumar S, Hoffman SL. "Autologous lymphoblastoid cell lines stably transfected with Plasmodium falciparum circumsporozoite protein as targets in cytotoxic T-lymphocyte assays." Immunology letters. 1997 Mar; 55(3):183-7.
1996 Oct 11
Mullen CA, Jennings PA. "Glycinamide ribonucleotide transformylase undergoes pH-dependent dimerization." Journal of molecular biology. 1996 Oct 11; 262(5):746-55.
1996 Jun 10
Mullen CA, Snitzer K, Culver KW, Morgan RA, Anderson WF, Blaese RM. "Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector." Human gene therapy. 1996 Jun 10; 7(9):1123-9.
1996 Mar 15
Mullen CA, Petropoulos D, Lowe RM. "Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes." Cancer research. 1996 Mar 15; 56(6):1361-6.
1996 Jan
Khil MS, Kim JH, Mullen CA, Kim SH, Freytag SO. "Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene." Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Jan; 2(1):53-7.
1995 Oct 20
Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. "T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years." Science. 1995 Oct 20; 270(5235):475-80.
1995 Oct
Ramsey WJ, Mullen CA, Blaese RM. "Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency." Leukemia. 1995 Oct; 9 Suppl 1:S70.
1995 Oct
Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A. "Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency." Nature medicine. 1995 Oct; 1(10):1017-23.
1995 May 15
Consalvo M, Mullen CA, Modesti A, Musiani P, Allione A, Cavallo F, Giovarelli M, Forni G. "5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory." The Journal of immunology : official journal of the American Association of Immunologists. 1995 May 15; 154(10):5302-12.
Kuriyama S, Masui K, Sakamoto T, Nakatani T, Tominaga K, Fukui H, Ikenaka K, Mullen CA, Tsujii T. "Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5-fluorocytosine". International Hepatology Communications. 1995; 4: 72-79. Link
1994 Dec
Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. "A multiinstitutional survey of the Wiskott-Aldrich syndrome." The Journal of pediatrics. 1994 Dec; 125(6 Pt 1):876-85.
1994 Aug
Mullen CA. "Metabolic suicide genes in gene therapy." Pharmacology & therapeutics. 1994 Aug; 63(2):199-207.
1994 Jun
Couture LA, Mullen CA, Morgan RA. "Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression." Human gene therapy. 1994 Jun; 5(6):667-77.
1994 Apr
Agbaria R, Mullen CA, Hartman NR, Cooney DA, Hao Z, Blaese RM, Johns DG. "Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction." Molecular pharmacology. 1994 Apr; 45(4):777-82.
1994 Mar 15
Mullen CA, Coale MM, Lowe R, Blaese RM. "Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor." Cancer research. 1994 Mar 15; 54(6):1503-6.
1993 Nov 15
Mullen CA, Anderson KD, Blaese RM. "Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases." Blood. 1993 Nov 15; 82(10):2961-6.
1993 Oct
Walker R, Blaese RM, Carter CS, Chang L, Klein H, Lane HC, Leitman SF, Mullen CA, Larson M. "A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins." Human gene therapy. 1993 Oct; 4(5):659-80.
1993 Oct
Blaese RM, Mullen CA, Ramsey WJ. "Strategies for gene therapy." Pathologie-biologie. 1993 Oct; 41(8):672-6.
1992 Nov 1
Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM. "Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential." Cancer research. 1992 Nov 1; 52(21):6020-4.
1992 Jan 1
Mullen CA, Kilstrup M, Blaese RM. "Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system." Proceedings of the National Academy of Sciences of the United States of America. 1992 Jan 1; 89(1):33-7.
1990 Dec
Mullen CA, Buchanan GR. "Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Dec; 8(12):1998-2004.
1989 Mar
Mullen CA, Rowley DA, Schreiber H. "Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity." Cellular immunology. 1989 Mar; 119(1):101-13.
1986 Apr 1
Abruzzo LV, Mullen CA, Rowley DA. "Immunoregulation by natural killer cells." Cellular immunology. 1986 Apr 1; 98(2):266-78.
1985 Nov 1
Mullen CA, Urban JL, Van Waes C, Rowley DA, Schreiber H. "Multiple cancers. Tumor burden permits the outgrowth of other cancers." The Journal of experimental medicine. 1985 Nov 1; 162(5):1665-82.
Mullen CA, Schreiber H. "Tumor growth and evasion of immune destruction: UV-induced tumors as a model." Survey of immunologic research. 1985 4(4):264-70.


Rodriguez N, Madden RM, Mullen CA. "Supportive Care in Pediatric Oncology: Part I". Pediatric Oncology. Chan KW, Raney RB. New York, NY: Springer, 2005. 208-217
Madden RM, Koontz-Webb S, Zhukovsky DS, Mullen CA. "Supportive Care in Pediatric Oncology: Part II". Pediatric Oncology. Chan KW, Raney RB. New York, NY: Springer, 2005. 218-243
Mullen CA. "Cytosine deaminase as a suicide gene in cancer gene therapy". Gene Therapy of Cancer. Lattime N, Gerson G. San Diego, CA: Academic Press, 1998. 201-208
Mullen CA. "Gene Therapy of Cancer". Encyclopedia of Cancer. Bertino JR. San Diego, CA: Academic Press, 1997. 693-703
Mullen CA, Blaese RM. "Gene therapy of cancer". Cancer Chemotherapy and Biological Response Modifiers. Pinedo HM, Longo DL, Chabner BA. Amsterdam, Neatherlands: Elsevier, 1996. 285-294
Mullen CA. "Development of live tumor vaccines using retroviral vectors for transfer of suicide genes and cytokines". Cytokines in Cancer Therapy. Bergmann L, Mitrou PS. Freiburg, Germany: Karger, 1994. 260-268
Mullen CA. "Herpes thymidine kinase suicide gene transfer: A review of preclinical models and proposals to treat brain tumors". Cytokine-Induced Tumor Immunogenicity. San Diego, CA: Academic Press, 1994. 455-465
Blaese RM, Mullen CA, Culver KW. "Progress in gene therapy for immunodeficiency and cancer". Klinische Pharmakologie. Hartmann D, Furuichi Y, Drews J. Munich, Germany: Frontiers in Biomedical Research, 1993. 65-80